Related Experiment Video
Updated: Jul 15, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Hantavirus cardiopulmonary syndrome
Betty Chang1, Mark Crowley, Matthew Campen
1Department of Internal Medicine, University of New Mexico Health Science Center, Albuquerque, New Mexico, USA.
Hantavirus cardiopulmonary syndrome (HCPS) is a severe illness caused by hantaviruses. Early intensive care and supportive treatments like ECMO improve survival rates for this condition.
Area of Science:
- Infectious Diseases
- Cardiology
- Pulmonology
Background:
- Hantavirus cardiopulmonary syndrome (HCPS) is a severe, often fatal, illness caused by hantaviruses in the Americas.
- All hantavirus strains can cause pulmonary capillary leak syndrome and cardiogenic shock, with a high overall mortality rate of 35%.
Purpose of the Study:
- To summarize the clinical presentation, diagnosis, and management of Hantavirus cardiopulmonary syndrome (HCPS).
- To highlight critical interventions that improve patient survival.
Main Methods:
- Review of clinical data and outcomes for patients with HCPS.
- Analysis of treatment strategies including fluid replacement, inotropic therapy, mechanical ventilation, and ECMO.
- Evaluation of therapeutic agents like ribavirin and hyperimmune serum.
Main Results:
- Severe HCPS presents with rapid respiratory failure and shock.
- Early recognition during the thrombocytopenic prodrome and intensive care are crucial for survival.
- Extracorporeal membrane oxygenation (ECMO) is life-saving for refractory shock.
- Hyperimmune serum shows promise, with survival correlating to higher neutralizing antibody titers.
Conclusions:
- Prompt diagnosis and intensive care are vital for managing HCPS.
- Supportive therapies, including ECMO, significantly improve outcomes.
- Hyperimmune serum represents a potential future therapeutic strategy for HCPS.
Related Concept Videos
Respiratory Syncytial Virus Disease
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Coronavirus

